logo
How microplastics harm the heart

How microplastics harm the heart

Indian Express30-06-2025
— Ghanshyam Kumar and Dr Bhanu Duggal
Cardiovascular diseases (CVDs) remain one of the leading causes of death globally, and growing evidence suggests that environmental factors may be silently worsening these health risks. Some recent studies have indicated a possible link between the severity of CVDs and microplastics – tiny fragments of plastic that infiltrate the human body through drinking water, everyday food items, fishery products, etc.
In addition to CVDs, microplastics have been linked to a wide range of health issues, including gut dysfunction, respiratory complications, kidney and liver damage, reproductive and developmental problems, and even neurological disorders. Let's understand what is microplastic and what are the health risks associated with it?
Microplastics are tiny particles of less than five millimetres in size. Their pervasive presence in the air we breathe, the water we drink, and the food we consume has emerged as a serious environmental concern.
Microplastics are broadly classified into primary microplastics – intentionally produced microplastics such as those found in cosmetics – and secondary microplastics – resulting from the decomposition of larger plastic materials.
Polyethylene terephthalate (PET), polystyrene (PS), polypropylene (PP), polyvinyl chloride (PVC), and polyethylene (PE) are among the most commonly used plastics/microplastics in various applications such as making plastic bottles, disposable cutlery, bags, piping, etc.
These conventional plastics are non-biodegradable and remain in the environment for a long time after their improper disposal. These plastics degrade into smaller particles through physical, chemical, or biological processes and persist in the environment due to their slow degradation rate.
Notably, plastic production has increased significantly during the past few decades, with annual output exceeding 400 million tons. It is estimated to reach more than 1 billion tons by 2060.
Microplastics are now ubiquitous and have been found even in remote uninhabited areas. Its widespread presence exposes all ecosystems – terrestrial as well as aquatic – and adversely affects plants, animals, and humans. Microplastics also act as carriers of other environmental pollutants such as heavy metals, persistent organic pollutants, and various toxic additives like plasticisers and stabilisers used during their manufacturing.
The human body is exposed to microplastics through inhalation, ingestion of contaminated food and water, and dermal contact. Drinking water, and everyday food items such as salts, crop plants, and fishery products have been found to contain microplastics.
Once inside the body, these particles can accumulate in various organs and enter the circulatory system, potentially causing harmful health effects. Microplastics have been found in biological fluids and organs such as semen, breast milk, urine, arteries, brain, liver, lung, heart, and placenta.
Various in vitro studies on different cell lines and in vivo studies on animals (rats, mice, zebrafish) and humans have demonstrated the toxicity of microplastics. It can lead to gut dysfunction, respiratory issues, kidney and liver damage, reproductive and developmental problems, neurological disorders, and cardiovascular diseases (CVDs).
According to the World Health Organization (WHO), CVDs are one of the most prevalent non-communicable diseases, accounting for around 27 per cent of total deaths in India in 2016. CVDs comprise various disorders of the heart and blood vessels and include diseases such as hypertension, stroke, myocardial infarction (commonly known as heart attacks), and congenital heart disease.
Heart attack, caused by the disruption of blood flow to the heart muscles, is one of the leading causes of mortality worldwide. These diseases not only cause significant mortality and morbidity but also result in high out-of-pocket medical expenses, loss of employment, mental health issues, and financial distress.
Hence, studying the toxicity of microplastics on cardiovascular health is crucial. The detection of microplastics in the human body can help protect vulnerable patients (high-risk populations), which will help reduce mortality and alleviate healthcare costs for both citizens and the government.
To date, there have been no studies in India on the cardiotoxicity of microplastics in humans. However, recent studies conducted globally have indicated a possible link between microplastics and the severity of CVDs. Microplastics have been shown to cause cardiotoxicity, which refers to damage to the heart muscle or its function, leading to complications such as abnormal heart rhythms (arrhythmias), heart failure, and structural damage to heart tissue.
Microplastics of varying shapes, sizes, and quantities have been detected in various cardiac tissues (including the pericardium, epicardial adipose tissue, myocardium, left atrial appendage, and pericardial adipose tissue) and in arteries (such as the coronary, cerebral, carotid, and aorta). Types of plastics identified include PVC, PET, PE, and PP, the most commonly used microplastics.
Microplastics have also been associated with adverse biological effects, including oxidative stress and inflammation, which can contribute to the development of atherosclerosis. Atherosclerosis is a condition in which plaque – composed of cholesterol, fatty substances, and calcium – accumulates inside the arteries, and leads to the narrowing of the arterial walls and disrupting blood flow to the heart muscle.
If the plaque ruptures, it can lead to the formation of thrombus (blood clot), which may block the artery entirely, disrupt blood flow, and subsequently cause cardiac cell injury and death – a condition commonly known as a heart attack (myocardial infarction).
Studies have shown that microplastic concentrations are higher in cardiac patients compared to control groups (non-cardiac patients). The presence of microplastics in the arteries has been linked to an increased risk of major adverse clinical outcomes, including death, heart attacks, heart failure, reduced cardiac function, and stroke during follow-up periods. Additionally, the severity of ischemic stroke has been found to be correlated with microplastic concentration.
However, the lack of suitable representative samples limits the generalisation of existing research findings to the Indian population. Most studies conducted so far have also used small sample sizes. A definitive cause-and-effect (causal) relationship between microplastics and cardiovascular diseases has yet to be established. Microplastics can merely be bystanders, as confounding variables – such as exposure to other environmental pollutants and comorbidities like diabetes and other diseases – can increase the severity of CVDs.
Therefore, future studies need to focus on understanding the cardiotoxicity of microplastics in India by conducting cohort studies across populations with varying levels of exposure to microplastic concentration. Such studies would be essential to establishing a causal relationship in the Indian context.
In 2022, the United Nations Environment Assembly passed a resolution to form an Intergovernmental Negotiating Committee (INC) tasked with developing a legally binding treaty to address plastic pollution. But the consensus has yet to be reached.
Now the upcoming INC-5.2 meeting scheduled for August 2025 offers some hope that a Global Plastic Treaty will be agreed upon – one that takes into account the concerns of stakeholders and advances global efforts to curb the menace of plastic pollution.
In the case of India, the government has taken practical steps to reduce the misuse of plastics, such as banning single-use plastics effectively from July 1, 2022. Implementing the 3Rs – reduce, recycle, reuse – of waste management will significantly help reduce plastic pollution. In addition, encouraging the use of environment-friendly biodegradable bioplastics such as polyhydroxyalkanoates can help. Moreover, increasing public awareness about the toxic effects of plastics and microplastics is vital in reducing their usage and associated health risks.
What are microplastics, and what are the health risks associated with it?
What steps has the government taken to mitigate plastic pollution and its health effects?
How can the principles of the 3Rs (Reduce, Reuse, Recycle) be effectively implemented in India to combat plastic waste?
What is the role of the United Nations Environment Assembly and the Intergovernmental Negotiating Committee (INC) in addressing global plastic pollution?
How could a Global Plastic Treaty contribute to reducing microplastic exposure and its health implications?
(Ghanshyam Kumar has worked as a Research Fellow at AIIMS Rishikesh and Dr. Bhanu Duggal is Professor and Head of the Department of Cardiology at AIIMS Rishikesh.)
Share your thoughts and ideas on UPSC Special articles with ashiya.parveen@indianexpress.com.
Subscribe to our UPSC newsletter and stay updated with the news cues from the past week.
Stay updated with the latest UPSC articles by joining our Telegram channel – IndianExpress UPSC Hub, and follow us on Instagram and X.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Over 500 nuclear medicine facilities available in govt, private sector: Jitendra Singh
Over 500 nuclear medicine facilities available in govt, private sector: Jitendra Singh

Hans India

time2 days ago

  • Hans India

Over 500 nuclear medicine facilities available in govt, private sector: Jitendra Singh

New Delhi: More than 500 nuclear medicine facilities are available in the government and private sectors, Union Minister of State for Department of Atomic Energy Jitendra Singh informed the Parliament on Wednesday. In a written reply in Lok Sabha, Singh shared information on nuclear energy's potential to be applied in the health sector for advanced treatment of various ailments. 'Nuclear medicine can be practiced in both diagnostics and therapeutics. In India, Single Photon Emission Computerised Tomography (SPECT), Positron Emission Tomography (PET), and Computerised Tomography (CT) are the devices through which diagnostic nuclear medicine is practiced,' Singh said. 'These help in staging, restaging, and response evaluation of cancer. There is availability of nuclear medicine facilities in the country in both the government and private sectors. There are more than 500 such facilities available,' he added. Nuclear medicine imaging provides unique information by helping doctors view how organs are functioning, which is different from X-rays or CT scans that show only anatomical structure. Further, Singh shared that the government has taken several initiatives to augment research and development of nuclear medicine in the country. 'R&D is ongoing in radioisotope production, purification, and development of new technologies to ensure an enhanced and uninterrupted supply of medical radioisotopes in the country," the MoS said. This includes several indigenously produced radiopharmaceutical products developed at Bhabha Atomic Research Centre (BARC). The products have also been launched for applications like radiation synovectomy, therapy of neuroendocrine tumours, breast cancer, bone pain palliation, liver cancer, and non-Hodgkin's lymphoma, Singh said. "BARC regularly produces radioisotopes and radiopharmaceuticals and supplies them through the Board of Radiation and Isotope Technology (BRIT) to various nuclear medicine centres across India, enabling broader availability of diagnostic and therapeutic services, including in rural and underserved areas," Singh said. In addition, Tata Memorial Centre, an aided institute under the aegis of the Department of Atomic Energy, has established P Ramaiah Naidu Shodhika -- an advanced Nuclear Medicine Research and Treatment unit in the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Mumbai. The facility has 41 hot beds, one of the largest therapeutic nuclear medicine units in the world and was inaugurated in 2023. It has state-of-the-art facilities for nuclear medicine and basic research. TMC has also established the Homi Bhabha Cancer Hospital and Mahamana Pt. Madan Mohan Malviya Cancer Centre at Varanasi, UP. There are 2 PET CT, 1 SPECT CT, High Dose Radioiodine Therapy, and a Theranotic Facility available for the use of nuclear medicine and diagnostic purposes, the Minister informed.

Persian Scholars in a Lurch Over Place of Research, Approved Guide
Persian Scholars in a Lurch Over Place of Research, Approved Guide

Time of India

time2 days ago

  • Time of India

Persian Scholars in a Lurch Over Place of Research, Approved Guide

Nagpur: A group of PhD aspirants in the Persian language have been left in the lurch, despite clearing the PhD Entrance Test (PET) conducted by Nagpur University four years ago. The candidates have been unable to complete their registration or begin their research work due to the prolonged unavailability of an approved guide and a recognised research centre, sources said. Initially, the students couldn't register because the only available PhD guide, Professor Mazhar Alam Siddique from Vasantrao Naik Government Institute of Arts and Social Sciences (VNGIASS), also known as Morris College, was nearing retirement. As he had less than three years remaining in his tenure, new PhD registrations under him were not permitted. After his retirement, the institute failed to renew its status as a recognised research centre. Although a new Persian professor has now been approved as a PhD guide, the department still lacks an official place of research, a prerequisite for registration, stalling the students' academic progress. Some frustrated candidates have been running from pillar to post for a solution, while others have shifted to different universities. Mohammad Reza, an Iranian national living in Mumbai, said he followed up multiple times and sent emails to university officials but received no response. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 8 speakeasy bars and restaurants in Singapore to check out CNA Undo "If there were no guide or research centre, why did the university conduct PET in the Persian subject? We've lost so much time," he lamented. Acting Pro-Vice Chancellor Subhash Kondawar, who took charge this year, said he would look into the matter and ensure its resolution. Former professor Siddique told TOI that he had suggested some of his students take the interdisciplinary faculty route, as he was barred from accepting new PhD registrations during the last three years of his service. "Some students were registered under political science, history, and philosophy in the Interdisciplinary Studies faculty to avoid loss of time. Their synopses were also submitted. However, these students too haven't been able to begin their research work, even though the PhD directions allow this approach," he said. He added that while the institute now has a newly approved guide, the renewal of research centre status is still pending and may take another six months.

Cancer care in crisis: PGI's slow procurement leaves patients in fix
Cancer care in crisis: PGI's slow procurement leaves patients in fix

Time of India

time19-07-2025

  • Time of India

Cancer care in crisis: PGI's slow procurement leaves patients in fix

Chandigarh: A year-long wait for a crucial cancer diagnosis tool, the Gallium-68 (Ga-68) isotope generator, has crippled the PGI's nuclear medicine department, forcing an increasing number of desperate cancer patients to seek costly tests at private centres. The delay, exacerbated by the 'Made in India' exemption clause in procurement policies, not only caused immense financial burden on families but also directly jeopardised timely cancer staging and treatment decisions. The Ga-68 generator, a vital component for Ga DOTA scans used in staging solid tumours, particularly neuroendocrine tumours, was out of stock for a few years, despite each generator lasting only six months. This critical scan helps doctors determine if cancer is localised or has spread, directly influencing life-saving treatment plans such as surgery, chemotherapy, or radiation therapy. The scan costs Rs 7,000 in PGI, which is almost four times more in a private centre. When PGI authorities were contacted, they did not respond. Adding to the woes, sources within the department revealed that even essential chemical reagents required for the cyclotron – which produces isotopes for cancer diagnosis and treatment – were in short supply. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like An engineer reveals: One simple trick to get internet without a subscription Techno Mag Learn More Undo In fact, some doctors are using their personal "learning resources allowance" to procure these vital chemicals. "We have no dearth of funding for patient utility," said a senior PGI doctor on condition of anonymity, "but the procurement process is so agonisingly slow that it poses a significant risk to cancer patients. Every day counts in cancer diagnosis and treatment." The core of the problem, according to PGI officials, lies in the 'Made in India' exemption clause, which, while well-intentioned, often snarls the procurement of essential medical equipment and reagents in bureaucratic red tape. This left the PGI struggling to acquire even basic radiopharmaceuticals like Oxygen-18 enriched water, crucial for Positron Emission Tomography (PET) scans in cancer detection.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store